跳至主要内容
临床试验/NCT06703372
NCT06703372已完成不适用

Effectiveness Of Photobiomodulation In Treatment Of Xerostomia In Type Ii Diabetic Patients (A Randomized, Controlled Clinical Trial)

Hams Hamed Abdelrahman1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2022年10月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Change in severity of xerostomia

研究概览

简要总结

Xerostomia is a major oral health problem that if not recognized and treated can have a significant effect on a patient's quality of life. It leads to difficulties with speech, swallowing and taste alteration. Pathological causes of xerostomia are divided into local and systemic factors. Local factors include smoking, salivary gland diseases and head and neck radiation therapy. Systemic factors include autoimmune diseases as Sjögren syndrome and hormonal disorders as Diabetes Mellitus. Photobiomodulation (PBM) previously known as Low Level Laser Therapy (LLLT) is the application of red and near infra-red light over injuries or lesions to improve wound and soft tissue healing, reduce inflammation and give relief for both acute and chronic pain. It also has grabbed the attention over the last few years as an effective treatment for xerostomia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
25 Years 至 50 Years(Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients with type 2 diabetes mellitus suffering from xerostomia and on oral hypoglycemic drugs.
  • •Glycated hemoglobin less than 7%.
  • •Duration of diabetes mellitus not less than 4 years and not more than 8 years

排除标准

  • •Patients receiving any drugs that cause hyposalivation.
  • •Patients with any systemic disease reported to produce hyposalivation (sjogren's syndrome, hepatitis c, rheumatoid arthritis and lupus erythematosus).
  • •Patients receiving chemotherapy and radiotherapy.
  • •Individuals with skin lesions in the treatment zone to avoid any complications occurring in this area by laser exposure

研究组 & 干预措施

Diode laser

Experimental

干预措施: Diode Laser 980 nm, 0.2W (Other)

placebo diode laser

Placebo Comparator

干预措施: Placebo Diode laser (Other)

结局指标

主要结局

Change in severity of xerostomia

时间窗: baseline, 2 weeks, 4 weeks, 6 weeks and 12 weeks

Summated Xerostomia Inventory-Dutch Version questionnaire (SXI-D) version will be used to assess the severity of xerostomia. Questions: * My mouth feels dry when eating a meal. * My mouth feels dry. * I have difficulty in eating dry foods. * I have difficulties swallowing certain foods. * My lips feel dry Scores: * Never scoring 1 * Occasionally scoring 2 * Ever scoring 3

Change in unstimulated salivary flow rate

时间窗: baseline, 2 weeks, 4 weeks, 6 weeks and 12 weeks

Hypo-salivation will be determined if the unstimulated salivary flow rate is 0.1- 0.2 ml/min or less

Change in stimulated salivary flow rate

时间窗: baseline, 2 weeks, 4 weeks, 6 weeks and 12 weeks

Whole-mouth SFR measurement will be conducted at every follow-up time point.

次要结局

未报告次要终点

研究者

发起方
Hams Hamed Abdelrahman
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Hams Hamed Abdelrahman

Assistant Lecturer of Dental Public Health and biostatistical consultanat

Alexandria University

研究点 (1)

Loading locations...

相似试验